PerkinElmer, Inc. (United States)
(NYSE : PKI)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. -0.39%334.771.0%$573.61m
MDTMedtronic Plc -0.33%113.490.6%$544.38m
BDXBecton, Dickinson & Co. -0.25%252.841.1%$534.36m
ISRGIntuitive Surgical, Inc. -1.00%612.102.4%$454.04m
ABTAbbott Laboratories -0.55%87.980.8%$395.08m
EWEdwards Lifesciences Corp. -0.64%232.411.2%$368.10m
DHRDanaher Corp. -0.51%159.440.7%$355.33m
BSXBoston Scientific Corp. -0.87%42.131.1%$313.74m
SYKStryker Corp. -0.65%223.011.3%$297.71m
DXCMDexCom, Inc. 0.17%303.018.2%$281.54m
ALGNAlign Technology, Inc. -1.55%268.266.4%$236.48m
BAXBaxter International, Inc. -0.17%92.901.8%$192.20m
ZBHZimmer Biomet Holdings, Inc. -0.07%158.281.7%$167.75m
TNDMTandem Diabetes Care, Inc. -0.38%89.603.9%$153.82m
ABMDABIOMED, Inc. -0.77%166.793.3%$136.04m

Company Profile

PerkinElmer, Inc. engages in the provision of products, services, and solutions for diagnostics, food, environmental, life sciences, and applied markets. It operates through the following two segments: Discovery & Analytical Solutions, and Diagnostics. The Discovery & Analytical Solutions segment comprises of technologies that help life sciences researchers better understand diseases and develop treatments. The Diagnostics segment offers instruments, reagents, assay platforms, and software to hospitals, medical labs, clinicians, and medical research professionals to help improve the health of families. The company was founded by Richard Scott Perkin and Charles W. Elmer on April 19, 1937 and is headquartered in Waltham, MA.